Pages that link to "Q46650361"
Jump to navigation
Jump to search
The following pages link to Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema (Q46650361):
Displaying 34 items.
- Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency (Q26801368) (← links)
- Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance (Q28079761) (← links)
- Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives (Q30414957) (← links)
- Pediatric hereditary angioedema (Q34805433) (← links)
- C1 inhibitor deficiency: 2014 United Kingdom consensus document (Q35667502) (← links)
- Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema (Q37737432) (← links)
- Managing the female patient with hereditary angioedema (Q37741790) (← links)
- Current pharmacotherapy of bradykinin-mediated angioedema. (Q38088259) (← links)
- Anaesthesia Management of a Patient with Hereditary Angioedema with Prophylactic Administration of C1 Esterase Inhibitor: Case report and literature review (Q38132170) (← links)
- The complement system in inflammatory bowel disease (Q38211992) (← links)
- The safety of treatments for angioedema with hereditary C1 inhibitor deficiency. (Q38597515) (← links)
- Optimizing hereditary angioedema management through tailored treatment approaches (Q38615008) (← links)
- Current treatment options for hereditary angioedema due to C1 inhibitor deficiency (Q38619062) (← links)
- Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey (Q38687395) (← links)
- Prophylaxis in hereditary angioedema (HAE) with C1 inhibitor deficiency (Q38772714) (← links)
- Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment (Q38790498) (← links)
- How we manage persons with hereditary angioedema. (Q38806437) (← links)
- Icatibant as acute treatment for hereditary angioedema in adults. (Q38819740) (← links)
- A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE). (Q38840241) (← links)
- Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema (Q39186418) (← links)
- Improving patient outcomes in hereditary angioedema: reducing attack frequency using routine prevention with C1 inhibitor concentrate (Q40108326) (← links)
- Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema (Q40117747) (← links)
- Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema (Q41590447) (← links)
- An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension (Q42371236) (← links)
- Progress with management of hereditary angioedema (Q43889557) (← links)
- Evaluating the efficacy of subcutaneous C1-esterase inhibitor administration for use in rat models of inflammatory diseases. (Q46016736) (← links)
- Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial (Q46462962) (← links)
- Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings (Q50916480) (← links)
- An analysis of the teaching of intravenous self-administration in patients with hereditary angio-oedema. (Q52856857) (← links)
- Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States (Q57472137) (← links)
- Hereditary angioedema: Linking complement regulation to the coagulation system (Q60952993) (← links)
- Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema (Q64044928) (← links)
- A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema (Q92991971) (← links)
- Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema (Q99581403) (← links)